Company Overview and News

2
St. Louis Jury Awards $4.7 Billion in Punitive Damages in J&J Asbestos Lawsuit

2018-07-13 biospace
In a particularly large result, a St. Louis jury awarded almost $4.7 billion in total damages to 22 women and their families in a lawsuit against Johnson & Johnson. Like many similar lawsuits, this case alleged that asbestos in J&J’s talcum powder contributed to ovarian cancer.
HON NK HON

0
Johnson and Johnson ordered to pay $742m in talc asbestos cancer case

2018-07-12 theage.com.au
Johnson & Johnson must pay at least $US550 million ($742 million) in damages to women who claimed asbestos in the company's talc products caused them to develop ovarian cancer, a St. Louis jury said.
NK VRX

0
Johnson and Johnson ordered to pay $742m in talc asbestos cancer case

2018-07-12 smh.com.au
Johnson & Johnson must pay at least $US550 million ($742 million) in damages to women who claimed asbestos in the company's talc products caused them to develop ovarian cancer, a St. Louis jury said.
NK VRX

0
J&J Ordered to Pay $550 Million in Talc Asbestos Cancer Case - Bloomberg

2018-07-12 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
NK VRX

164
J&J Faces High-Stakes Trial Over 22 Women's Talc Claims - Bloomberg

2018-06-06 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
NK VRX

0
Imerys unit settles talc claims for at least US$5 million: Bloomberg

2018-06-01 channelnewsasia
A unit of French minerals company Imerys SA settled claims by 22 women related to talc supplied to Johnson & Johnson for making baby powder for at least US$5 million, Bloomberg reported on Friday, citing people familiar with the matter.
NK

0
Imerys unit settles talc claims for at least $5 mln -Bbg

2018-06-01 reuters
(Reuters) - A unit of French minerals company Imerys SA settled claims by 22 women related to talc supplied to Johnson & Johnson for making baby powder for at least $5 million, Bloomberg reported on Friday, citing people familiar with the matter.
NK

135
U.S. jury fails to reach verdict in latest J&J talc trial

2018-05-27 reuters
NEW YORK (Reuters) - A South Carolina jury on Friday could not agree on a verdict in a case of a woman whose family said her long-term use of Johnson & Johnson’s Baby Powder led to her death from asbestos-related cancer, resulting in a mistrial.
NK RAD

135
US jury fails to reach verdict in latest J&J talc trial

2018-05-27 channelnewsasia
A South Carolina jury on Friday could not agree on a verdict in a case of a woman whose family said her long-term use of Johnson & Johnson's Baby Powder led to her death from asbestos-related cancer, resulting in a mistrial.
NK RAD

0
Johnson & Johnson ordered to pay woman $34 million in baby powder trial

2018-05-25 theage.com.au
Johnson & Johnson was ordered by a California jury to pay $US25.7 million ($34 million) in damages to a 68-year-old woman who claimed her deadly cancer was caused by asbestos in the company's baby powder.
NK

0
Johnson & Johnson ordered to pay woman $34 million in baby powder trial

2018-05-25 smh.com.au
Johnson & Johnson was ordered by a California jury to pay $US25.7 million ($34 million) in damages to a 68-year-old woman who claimed her deadly cancer was caused by asbestos in the company's baby powder.
NK

137
J&J must pay US$4 million in punitive damages in latest asbestos cancer trial

2018-05-25 channelnewsasia
A California jury on Thursday ordered Johnson & Johnson to pay US$4 million in punitive damages to a woman who said she developed cancer after being exposed to asbestos in the company's baby powder, pushing the total damages award in the case to US$25.7 million.
HON NK HON RAD

137
J&J hit with US$21.7 million verdict in another talc asbestos cancer case

2018-05-25 channelnewsasia
Johnson & Johnson and its talc suppliers on Wednesday were hit with a US$21.7 million jury verdict in a lawsuit by a woman who said she developed cancer after being exposed to asbestos in the company's Baby Powder.
HON NK HON RAD

137
Johnson & Johnson Loses $21.7 Million Verdict over Talc Asbestos Cancer Link

2018-05-25 biospace
A Los Angeles jury sided with 68-year-old Joanne Anderson, who was diagnosed with mesothelioma allegedly linked to a Johnson & Johnson talc product. It is the second similar award regarding the product. The jury awarded Anderson compensatory damages of $21.7 million. J&J is responsible for 67 percent of the award, with the remainder spread out among the other defendants.
HON NK HON RAD

135
RPT-J&J defends itself in trial over baby powder asbestos claims

2018-05-14 reuters
May 14 (Reuters) - A trial for a lawsuit alleging that Johnson & Johnson Baby Powder was responsible for the death of a woman due to her exposure to cancer-causing asbestos began in South Carolina on Monday in the latest case against the healthcare conglomerate and a supplier over their talc-based products.
NK RAD

Related Articles

CYTX: Cytori Therapeutics Analysis and Research Report

1h - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CATB: Catabasis Pharmaceuticals Analysis and Research Report

2018-07-13 - Asif

Overview Catabasis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics based on its proprietary Safely Metabolized And Rationally Targeted linker, or SMART LinkerSM, drug discovery platform. The company's SMART Linker drug discovery platform enables it to engineer product candidates that can simultaneously modulate multiple targets in a disease. The company's proprietary product candidates impact pathways that are central to diseases where efficacy may be optimized by a multiple target approach. Catabasis Pharmaceuticals has applied its SMART Linker drug discovery platform to build an internal pipeline of product candidates for rare diseases, its primary focus, and plan to pursue partnerships to develop additional product candidates. The company's lead product candidate is edasalonexent, formerly known as CAT-1004, which the company believe has the potential to be a disease-modifying...

WMT: Walmart Analysis and Research Report

2018-07-09 - Asif

Overview Walmart Inc. helps people around the world save money and live better – anytime and anywhere – in retail stores and through eCommerce. Through innovation, Walmart is striving to create a customer-centric experience that seamlessly integrates its eCommerce and retail stores in an omni-channel offering that saves time for its customers. Each week, the company serve nearly 270 million customers who visit its more than 11,700 stores and numerous eCommerce websites under 65 banners in 28 countries. The company's strategy is to lead on price, invest to differentiate on access, be competitive on assortment and deliver a great experience. Leading on price is designed to earn the trust of its customers every day by providing a broad assortment of quality merchandise and services at everyday low prices ("EDLP"). EDLP is its pricing philosophy under which the company price items at a low price every day so its customers trust that its prices will not change under frequent prom...

Silicon Investor Message Boards

This table lists all message boards related to EPA:NK / IMERYS on message board site Silicon Investor.

The *NEW* Frank Coluccio Technology Forum Franklin, Andrews, Kramer u0026 Edelstein
Dutch Central Bank Sale Announcement Imminent? News Links and Chart Links
Shipping - Oil u0026 Gas Tankers, Dry cargo, LNG NKTR Drug delivery Company
Plinking,Target-Shooting and other forms of Mayhem Mr. Pinku0027s Picks: selected event-driven value investments
Basketball Junkie Forum (NBA) NIKE NKE